Fixed-dose combination bictegravir, emtricitabine, and...

The Lancet HIV 2020 / 06 Vol. 7; Iss. 6

Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials

Orkin, Chloe, DeJesus, Edwin, Sax, Paul E, Arribas, Jose R, Gupta, Samir K, Martorell, Claudia, Stephens, Jeffrey L, Stellbrink, Hans-Jurgen, Wohl, David, Maggiolo, Franco, Thompson, Melanie A, Podzam
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Journal:
The Lancet HIV
DOI:
10.1016/S2352-3018(20)30099-0
Date:
June, 2020
File:
PDF, 661 KB
2020
Conversion to is in progress
Conversion to is failed